Many LGBT individuals believe HIV, AIDS are priority concern over other chronic diseases that affect LGBT communities
June 11, 2020 A quarter of participants in a national phone survey believe HIV and AIDS are the most serious health concerns LGBT communities are currently facing, over tobacco use and other chronic conditions, according to research from the Gillings School.
Warnings on sugary drinks could reduce consumer purchasing and consumption
June 3, 2020 Warnings on sugary drinks could reduce a person's intent to purchase and consume them, according to new findings from Dr. Anna Grummon and Dr. Marissa Hall.
Researchers map how coronavirus infection travels through cells of nasal cavity and respiratory tract
June 2, 2020 A major study of novel coronavirus infection in human airways adds to evidence that wearing a mask is an important step toward limiting transmission of COVID-19. The lead authors of the study in the journal Cell are UNC-Chapel Hill virology expert Dr. Ralph Baric and pulmonary expert Dr. Richard Boucher.
‘Landmark’ study finds long-acting injectable drug highly effective in preventing HIV
June 1, 2020 A large-scale HIV study funded by NIAID and ViiV Healthcare halted early after cabotegravir, dosed every two months, showed higher efficacy than a daily oral pill.
Medical home care has mixed effect on patients with mental and physical illnesses, UNC research shows
May 27, 2020 For patients with both mental and physical illnesses, medical home care could decrease hospital admissions and increase access to outpatient services, according to new findings from researchers in the Department of Health Policy and Management.
UNC researchers say COVID-19 treatment tocilizumab should be used with caution
May 26, 2020 In the first COVID-19 case series study of tocilizumab in the United States, UNC researchers report sobering results. They say the drug should be used judiciously until randomized clinical trials determine tocilizumab’s true efficacy.
Gillings scientists study most potent neutralizing antibody against novel coronavirus to date
May 21, 2020 By “fishing” in a pool of more than one hundred billion potential antibodies — using a piece of the SARS-CoV-2 spike protein as bait — infectious disease scientists have isolated human monoclonal antibodies that completely neutralize the SARS-CoV-2 virus that causes COVID-19.
Study finds excess medical costs associated with metastatic breast cancer, especially among younger women
May 20, 2020 Medical costs for metastatic breast cancer treatment are considerably higher than earlier-stage treatments, especially for younger women, according to a new study co-authored by Dr. Justin Trogdon and Dr. Stephanie Wheeler.
The Gillings Community Responds to COVID-19: Tracking the Spread
May 18, 2020 The asymptomatic transmission of COVID-19 has created a significant challenge for public health experts. Learn how faculty and alumni in epidemiology, health behavior and biostatistics are working to track the spread of the disease through studies, contact tracing, modeling and more.
Gillings researchers advance in the quest for a dengue vaccine
May 13, 2020 Dengue viruses are estimated to cause ~390 million infections and 100 million cases each year around the globe. Because infection with one of the four unique dengue strains does not provide lasting immunity to the other strains, it has been especially difficult to create an effective vaccine.
